579 related articles for article (PubMed ID: 28438689)
21. Noncoding RNAs in liver cancer stem cells: The big impact of little things.
Lv H; Lv G; Han Q; Yang W; Wang H
Cancer Lett; 2018 Apr; 418():51-63. PubMed ID: 29307614
[TBL] [Abstract][Full Text] [Related]
22. Role of microRNA and Long Non-Coding RNA in Hepatocellular Carcinoma.
Gupta M; Chandan K; Sarwat M
Curr Pharm Des; 2020; 26(4):415-428. PubMed ID: 31939724
[TBL] [Abstract][Full Text] [Related]
23. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis.
Wang X; Sun W; Shen W; Xia M; Chen C; Xiang D; Ning B; Cui X; Li H; Li X; Ding J; Wang H
J Hepatol; 2016 Jun; 64(6):1283-94. PubMed ID: 26812074
[TBL] [Abstract][Full Text] [Related]
25. Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinoma.
Law PT; Qin H; Ching AK; Lai KP; Co NN; He M; Lung RW; Chan AW; Chan TF; Wong N
J Hepatol; 2013 Jun; 58(6):1165-73. PubMed ID: 23376363
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma.
Parasramka MA; Maji S; Matsuda A; Yan IK; Patel T
Pharmacol Ther; 2016 May; 161():67-78. PubMed ID: 27013343
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA UCA1 regulates the expression of Snail2 by miR-203 to promote hepatocellular carcinoma progression.
Xiao JN; Yan TH; Yu RM; Gao Y; Zeng WL; Lu SW; Que HX; Liu ZP; Jiang JH
J Cancer Res Clin Oncol; 2017 Jun; 143(6):981-990. PubMed ID: 28271214
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition.
Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC
Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837
[TBL] [Abstract][Full Text] [Related]
30. Non-coding RNAs in hepatitis B or C-associated hepatocellular carcinoma: potential diagnostic and prognostic markers and therapeutic targets.
Zhang Q; Pu R; Du Y; Han Y; Su T; Wang H; Cao G
Cancer Lett; 2012 Aug; 321(1):1-12. PubMed ID: 22425745
[TBL] [Abstract][Full Text] [Related]
31. Role of microRNAs in the main molecular pathways of hepatocellular carcinoma.
Vasuri F; Visani M; Acquaviva G; Brand T; Fiorentino M; Pession A; Tallini G; D'Errico A; de Biase D
World J Gastroenterol; 2018 Jul; 24(25):2647-2660. PubMed ID: 29991871
[TBL] [Abstract][Full Text] [Related]
32. Long Non-Coding RNAs as Mediators of Tumor Microenvironment and Liver Cancer Cell Communication.
Lin YH; Wu MH; Yeh CT; Lin KH
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477236
[TBL] [Abstract][Full Text] [Related]
33. Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma.
Jayachandran A; Dhungel B; Steel JC
J Hematol Oncol; 2016 Aug; 9(1):74. PubMed ID: 27578206
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
[TBL] [Abstract][Full Text] [Related]
35. The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling.
Wang Y; He L; Du Y; Zhu P; Huang G; Luo J; Yan X; Ye B; Li C; Xia P; Zhang G; Tian Y; Chen R; Fan Z
Cell Stem Cell; 2015 Apr; 16(4):413-25. PubMed ID: 25842979
[TBL] [Abstract][Full Text] [Related]
36. Road to stemness in hepatocellular carcinoma.
Flores-Téllez TN; Villa-Treviño S; Piña-Vázquez C
World J Gastroenterol; 2017 Oct; 23(37):6750-6776. PubMed ID: 29085221
[TBL] [Abstract][Full Text] [Related]
37. Astragaloside IV inhibits cell migration and viability of hepatocellular carcinoma cells via suppressing long noncoding RNA ATB.
Li Y; Ye Y; Chen H
Biomed Pharmacother; 2018 Mar; 99():134-141. PubMed ID: 29331759
[TBL] [Abstract][Full Text] [Related]
38. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications.
Niu ZS; Niu XJ; Wang WH
World J Gastroenterol; 2017 Aug; 23(32):5860-5874. PubMed ID: 28932078
[TBL] [Abstract][Full Text] [Related]
40. The Hippo pathway in hepatocellular carcinoma: Non-coding RNAs in action.
Shi X; Zhu HR; Liu TT; Shen XZ; Zhu JM
Cancer Lett; 2017 Aug; 400():175-182. PubMed ID: 28461246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
